Leading this frontier is Professor James McGrath of the Department of Biomedical Engineering, whose work centers on the development of translational microphysiological systems. These “tissue chips” replicate the interface between vascular and neural tissues, allowing unprecedented observation of cellular and molecular dynamics at the blood-brain barrier. By simulating pathological states such as the cytokine storm—a hyperinflammatory condition associated with severe infections and surgical traumas—McGrath’s group is dissecting how inflammatory mediators compromise barrier integrity, ultimately fostering brain injury.

The cornerstone of their recent study published in Advanced Science reveals that the blood-brain barrier’s safeguard function deteriorates when exposed to a confluence of inflammatory cytokines and blood-derived proteins like fibrinogen. This dual assault perturbs astrocytes, star-shaped glial cells integral to neuronal support and barrier maintenance, triggering detrimental signaling cascades. Intriguingly, their data elucidate the protective role of hemodynamic forces; physiological blood flow generates shear stress that bolsters barrier robustness against inflammatory insults. This interplay of biomechanical and biochemical factors underscores the necessity of integrated bioengineering approaches to decode neurovascular health.

Moreover, the Rochester team aims to enrich the brain side of their chip models. Incorporating microglia—the resident immune cells of the brain—into these platforms will illuminate their involvement in neuroinflammatory processes and neuronal damage. Enhanced complexity in these tissue chips could provide insights into drug responses and resilience factors, transforming them into versatile avatars for personalized medicine. The ultimate aspiration is to predict and prevent cognitive decline in patients vulnerable to cytokine storms, markedly improving clinical outcomes.

Parallel to this exploration is a complementary study published in Materials Today Bio, focusing on the enigmatic pericytes. These mural cells envelop endothelial cells that form the blood vessels and contribute substantially to barrier stability. McGrath’s group engineered deliberate disruptions in endothelial layers within their microchips to observe pericyte responses. Their findings demonstrate that pericytes actively repair basement membrane defects by producing a fibrous matrix, facilitating endothelial cells in reestablishing their selective permeability. This mechanism offers vital clues into pericyte depletion observed in neurodegenerative diseases and systemic inflammation.

The intricate crosstalk between pericytes and endothelial elements revealed by these engineered models marks a significant advancement in understanding vascular pathology in the brain. Since pericyte loss correlates with conditions like Alzheimer’s disease and multiple sclerosis, leveraging this in vitro system to test therapeutic strategies that bolster pericyte function opens exciting translational avenues. Biomedical engineering PhD student Michelle Trempel, a key contributor, emphasizes how this platform could simulate pathological states where pericyte deficiency exacerbates neurovascular dysfunction.

Together, these studies epitomize the convergence of bioengineering, immunology, and neuroscience to tackle formidable challenges in brain health. They illustrate the potential of human-relevant tissue chips to replace animal models, delivering more physiologically accurate and ethically sound solutions. Supported by grants from the National Institutes of Health and fellowships from ethical research foundations, this research exemplifies the forward momentum in microphysiological systems.

Critical collaborators include Harris (Handy) Gelbard, director of the Center for Neurotherapeutics Discovery at University of Rochester Medical Center, along with international experts Niccolò Terrando from Duke University and Britta Engelhardt from the University of Bern. Their collective expertise enriches the multidisciplinary fabric essential to success in this domain.

As the field advances, the integration of diverse brain components and patient-specific genetic variations into high-throughput tissue chip arrays could revolutionize drug discovery pipelines. Screening libraries of neuroprotective agents rapidly and efficiently may soon become a reality, significantly reducing the time and cost associated with bringing neurologically-targeted therapies to market.

This transformative technology also opens doors to precision medicine paradigms, where a chip replicating an individual’s brain barrier could preemptively evaluate risks associated with treatments known to provoke inflammatory cascades, such as chemotherapy or major surgeries. The capacity to tailor interventions to mitigate cognitive complications before they manifest heralds a new era in clinical neuroscience.

In sum, the University of Rochester’s tissue chip innovations stand at the intersection of cutting-edge engineering and medical science, poised to illuminate the dark complexities of brain barrier pathology and usher in next-generation therapies for neuroinflammatory and degenerative diseases. Their work signals a leap toward more humane, accurate, and personalized investigation tools that honor both scientific rigor and ethical stewardship.

Subject of Research: Blood-brain barrier integrity and neuroinflammation studied via human tissue chips
Article Title: Pericytes repair engineered defects in the basement membrane to restore barrier integrity in an in vitro model of the blood-brain barrier
News Publication Date: 26-Sep-2025
Web References: https://doi.org/10.1002/advs.202508271, http://dx.doi.org/10.1016/j.mtbio.2025.102361
Image Credits: University of Rochester photo / J. Adam Fenster
Keywords: Brain tissue, Blood brain barrier, Brain, Nervous system, Organismal biology, Biomedical engineering, Medical technology, Tissue, Sepsis, Cytokine storm, Endothelial cells, Animal experimentation

At the heart of this innovation lies the integration of multiplexed fluorescence imaging, which can distinguish the activities of neurons and astrocytes by tagging these cells with distinct fluorescent markers, with the comprehensive spatial resolution of magnetic resonance imaging (MRI). By fusing these complementary imaging techniques, HyFMRI allows researchers to simultaneously capture biochemical and physiological dynamics across wide brain regions without the limitations imposed by traditional methods that usually focus on isolated elements or require invasive procedures.

The novel approach addresses a critical gap in neuroimaging: capturing concurrent functional signals from multiple cell types while monitoring their hemodynamic context. Understanding these dynamics is essential because neurons rely not only on electrical impulses but also on astrocytic support and vascular responses to sustain complex brain functions. Previous imaging techniques have struggled to provide a holistic view, often focusing exclusively on either neuronal activity or blood oxygenation level-dependent (BOLD) signals, leaving astrocytes—and their role in neurometabolic coupling—largely elusive.

HyFMRI leverages advanced fluorescent reporter proteins engineered to respond to electrical and calcium signals specifically in neurons and astrocytes. These reporters enable differentiation and tracking of cellular activities in vivo. Meanwhile, the MRI component delivers volumetric data on blood flow and oxygenation, bridging a critical link between cellular signaling and vascular responses. The simultaneous acquisition of these datasets facilitates the mapping of neurovascular coupling with high temporal and spatial fidelity.

One of the standout capabilities of HyFMRI is its non-invasive application, which crucially preserves the integrity of the brain’s microenvironment. Unlike invasive electrophysiological methods or fluorescence microscopy restricted to superficial layers, this technique probes deeper structures while maintaining broad coverage. This attribute is especially valuable for longitudinal studies monitoring disease progression, therapeutic responses, or neurodevelopmental processes over extended periods.

The technical synergy was achieved by designing a specialized imaging setup synchronized to coordinate the excitation and emission of multiplexed fluorescent signals alongside MRI data acquisition sequences. This coordination mitigates signal cross-talk and artifact formation that could otherwise degrade image quality. Moreover, innovative computational algorithms process and integrate the multimodal data in real time, enhancing signal extraction and enabling dynamic correlation analyses of neural, astrocytic, and vascular interactions.

Preclinical applications in rodent models demonstrated the method’s prowess. The team was able to visualize stimulus-evoked neuronal firing patterns concurrently with astrocytic calcium waves and corresponding hemodynamic fluctuations. These findings underscore the interdependence of cellular and vascular responses, furnishing critical clues to underlying mechanisms in sensory processing and brain energetics, thereby advancing our understanding of fundamental brain function.

Importantly, HyFMRI holds the promise to revolutionize the study of neurological disorders where aberrant neurovascular coupling and astrocyte dysfunction have been implicated, including Alzheimer’s disease, stroke, epilepsy, and neuroinflammation. By providing detailed spatiotemporal maps of pathological alterations in cellular and vascular dynamics, this method offers a powerful tool for early diagnosis, monitoring, and the evaluation of therapeutic interventions.

Beyond clinical implications, the ability to visualize simultaneous activities of neurons and astrocytes alongside cerebral hemodynamics offers a richer canvas for neuroscience research. It can illuminate the roles astrocytes play in modulating synaptic activity, plasticity, and neuronal metabolism within intact networks. This could reshape prevailing models that historically marginalized glial cells to mere support roles, highlighting their active participation in brain computations.

The researchers also emphasize the technique’s adaptability. HyFMRI could be tailored to target various cellular markers beyond neurons and astrocytes by incorporating additional fluorescent probes. Such flexibility extends its applications to diverse studies involving microglia, oligodendrocytes, or even genetically encoded biosensors reporting neurotransmitters or metabolic states, thus expanding its utility across neuroscience disciplines.

While the current iteration mainly targets rodent models, efforts are underway to refine HyFMRI for potential human applications. Challenges including scaling the fluorescence detection sensitivity and adapting MRI protocols for clinical scanners are active areas of development. The eventual translation of this technology to human neuroimaging could transform diagnostics and research, enabling non-invasive, multi-modal monitoring of brain health and disease with cellular resolution.

This breakthrough also stimulates the dialogue surrounding multimodal imaging integration. The successful marriage of fluorescence multiplexing with MRI offers a blueprint for future innovations combining optical and magnetic resonance technologies, encouraging the exploration of new hybrid systems. Such interdisciplinary advancements rely on collaboration across bioengineering, optics, neurobiology, and medical imaging fields.

Ultimately, HyFMRI exemplifies the power of convergent technologies to disentangle the brain’s complexity. By illuminating the concurrent dynamics of neuronal activity, astrocytic signaling, and vascular responses, scientists now possess a more holistic lens to decode brain function. This advancement brings us closer to comprehending how cellular interplay orchestrates cognition, behavior, and neuropathology in the living brain.

The study, published in Light: Science & Applications, marks a milestone in neuroimaging that could redefine brain research in the years to come. It extends beyond mere imaging innovation, offering a versatile platform poised to accelerate discoveries in neuroscience and medicine. As further refinements and applications emerge, HyFMRI may soon become indispensable in laboratories and clinics worldwide.

Intriguingly, the hybrid system provides rich, multidimensional datasets that also invite the integration of artificial intelligence and machine learning algorithms. These tools can dissect the complex spatiotemporal patterns uncovered by HyFMRI, facilitating automated identification of network states, prediction of disease trajectories, or personalized therapeutic adjustments, pushing the frontiers of precision neuroscience.

In conclusion, Hybrid Multiplexed Fluorescence and Magnetic Resonance Imaging sets a new standard for functional brain imaging. Its capacity to concurrently capture multi-cellular signaling alongside vascular dynamics non-invasively heralds a transformative era in brain research. This work underscores the potential of hybrid imaging modalities to unravel the brain’s inner workings with unprecedented clarity and scale.

Subject of Research: Hybrid neuroimaging techniques integrating multiplexed fluorescence and magnetic resonance imaging for simultaneous detection of neuronal, astrocytic, and hemodynamic activity.

Article Title: Non-invasive large-scale imaging of concurrent neuronal, astrocytic, and hemodynamic activity with hybrid multiplexed fluorescence and magnetic resonance imaging (HyFMRI).

Article References:
Chen, Z., Chen, Y., Gezginer, I. et al. Non-invasive large-scale imaging of concurrent neuronal, astrocytic, and hemodynamic activity with hybrid multiplexed fluorescence and magnetic resonance imaging (HyFMRI). Light Sci Appl 14, 341 (2025). https://doi.org/10.1038/s41377-025-02003-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41377-025-02003-9